BioNote: Corporate value-up plan

This is a voluntary filing in which BioNote lays out its plan to raise corporate value, often tied to improving a low price-to-book (PBR) ratio, under Korea's Value-up program. It usually signals management's stated priorities, such as profitability or shareholder returns, but this filing title alone does not tell us the specific measures or targets. BioNote filed this on Oct 22, 2026.

Company filing